Page 242 - ESHRE2019

P-321 Transvaginal hydrolaparoscopy versus hysterosalpingography to assess tubal pathology in subfertile women: a randomised controlled trial
M. Van Kessel1, R. Tros2, J. Oosterhuis3, W. Kuchenbecker4, S. Van Kuijk5, M. Bongers6, B.W. Mol7, C. Koks8
1Medische Spectrum Twente, Gynecology, Enschede, The Netherlands 2VU medical center, gynecology, Amsterdam, The Netherlands
3St. Antonius Hospital, gynecology, Nieuwegein, The Netherlands 4Isala, gynecology, Zwolle, The Netherlands
5Maastricht University Medical Centre, Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht, The Netherlands
6Maastricht University Medical Centre, GROW – School for Oncology and Developmental Biology, Maastricht, The Netherlands
7Monash University, gynecology, Clayton, Australia
8Maxima Medical Center, gynecology, Veldhoven, The Netherlands
P-322 Changes in some transcription factors expression influencing on CD4+ T cells differentiation in endometriosis
N. Bajool1,2, S. Chegeni2,3, F. Ramezanali4, E. Amirchaghmaghi5, M. Shahhoseini2
1College of BioScience- Islamic Azad University North Tehran Branch- Tehran- Iran., Department Cell and Molecular Biology, Tehran, Iran
2Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR- Tehran- Iran., Department of Genetics, Tehran, Iran
3Faculty of Biological Sciences- Kharazmi University-Tehran-Iran, Department of Cellular & Molecular Biology, Tehran, Iran
4Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR- Tehran- Iran, Department of Endocrinology and Female Infertility, Tehran, Iran
5Cell Science Research Center- Royan Institute for Stem Cell Biology and Technology- ACECR- Tehran-Iran, Department of Regenerative Biomedicine, Tehran, Iran
P-323 Evaluation of tubal patency in 2018: the place of ultrasound with the use of an hyperechogenic medium, a franco-belgian survey
M. Pinto1, A. Delevigne2, C. Villette1, M. Pasquier1, C. Pietin-Vialle1, J.M. Levaillant1, N. Massin1
1Intercommunal Hospital of Creteil, Department of Gynecology-Obstetrics and Reproductive Medicine, Creteil- 94000, France
2Saint Vincent Private Hospital, Department of Reproductive Medicine, 4000 Rocourt, Belgium
P-324 Interleukin-33 modulates inflammation and may be treated as a biomarker in endometriosis
S. Ghosh1, P. Chakraborty2, S. Chatterjee3, R. Chattopadhyay4, S.K. Goswami4, P. Ghosh5, K. Dutta Chowdhury5, M. Chakravarty4, B. Chakravarty4
1Institute of Reproductive Medicine, ART, Calcutta, India
2Institute of Reproductive Medicine, Department of Infertility, Calcutta, India
3Vidyasagar College, Tissue culture and Molecular Biology Laboratory, Calcutta, India 4Institute of Reproductive Medicine, Department of Assisted Reproduction, Calcutta, India 5Rammohan College, Department of Zoology, Calcutta, India
242